The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
Kanz
L
L
Department of Hematology/Oncology Medical Center, University of Freiburg, Germany.
Brugger
W
W
Mertelsmann
R
R
D015703:Antigens, CD; D018952:Antigens, CD34; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000517:prevention & control; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D015672:Erythroid Precursor Cells / Q000276:immunology / Q000637:transplantation; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy
D015703:Antigens, CD; D018952:Antigens, CD34; D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors